Do sulphonylureas still have a place in clinical practice?

Sulphonylureas have been commercially available since the 1950s, but their use continues to be associated with controversy. Although adverse cardiovascular outcomes in some observational studies have raised concerns about sulphonylureas, findings from relatively recent, robust, and high-quality syst...

Full description

Bibliographic Details

Published in:	The lancet. Diabetes & endocrinology Vol. 6; no. 10; p. 821
Main Authors:	Khunti, Kamlesh, Chatterjee, Sudesna, Gerstein, Hertzel C, Zoungas, Sophia, Davies, Melanie J
Format:	Journal Article
Language:	English
Published:	England 01.10.2018
Subjects:	Cardiovascular Diseases - chemically induced Cardiovascular Diseases - complications Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - adverse effects Randomized Controlled Trials as Topic Risk Factors Sulfonylurea Compounds - adverse effects Treatment Outcome
ISSN:	2213-8595, 2213-8595
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!